Method for determining in-vitro sterilization effect of antibacterial drug on mycobacterium tuberculosis by using flow cytometry
The bactericidal effect of antibacterial drugs on Mycobacterium tuberculosis is rapidly analyzed through flow cytometry and dual fluorescence staining technology, which solves the problem of long cycles of traditional methods, achieves efficient and accurate drug sensitivity detection, and provides clinical antibacterial drugs. Quick assessment of the effect.
Patent Information
- Application Number
- CN202411303903.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-19
- Publication Date
- 2024-11-08
Smart Images

Figure CN118910207A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of drug sensitivity detection, and specifically relates to a method for measuring the in vitro bactericidal effect of antibacterial drugs on Mycobacterium tuberculosis by using flow cytometry. Background Art
[0002] Tuberculosis (TB), an ancient chronic infectious disease caused by Mycobacterium tuberculosis (Mtb), still seriously endangers human health, especially affecting the poorest and most vulnerable groups. In the past 2000 years, TB has caused more than 1 billion deaths, and about 1.5 million people still die from TB every year worldwide. Therefore, the prevention and treatment of tuberculosis has always been highly valued.
[0003] The study of non-clinical pharmacodynamics of antimicrobial drugs can indirectly reflect the dynamic process of antimicrobial drugs entering the body and then achieving antibacterial or bactericidal effects in the infected lesions, predict the bactericidal or antibacterial effects of drugs in the human body, and have important reference value for clinical research and formulation of dosing regimens. In traditional technology, the study of drug sensitivity of Mycobacterium tuberculosis is generally carried out by colony culture counting, and the culture cycle is generally about 28 days. The long research cycle seriously affects the test cycle of the bactericidal effect of antimicrobial drugs on Mycobacterium tuberculosis treatment drugs. Summary of the invention
[0004] In order to solve the above defects and shortcomings in the prior art, the present invention provides a method and application of flow cytometry in identifying the in vitro drug sensitivity of Mycobacterium tuberculosis, which can not only greatly reduce the detection cycle of non-clinical drug sensitivity, but also has high accuracy and is convenient and fast.
[0005] In order to solve the above technical problems, the present invention provides a method for determining the in vitro bactericidal effect of antibiotics on Mycobacterium tuberculosis by flow cytometry. The bactericidal effect of Mycobacterium tuberculosis after being acted on by gradient concentrations of antibiotics is analyzed by flow cytometry to obtain the drug concentration with the best in vitro bactericidal effect on Mycobacterium tuberculosis.
[0006] Further, the following steps are included: S1 Preparation of bacterial solution to be tested; S2 Drug sensitivity test of Mycobacterium tuberculosis: Using the proportional method, the minimum inhibitory concentration (MIC) of Mycobacterium tuberculosis is determined by counting colonies; S3 Bactericidal test of drugs at different concentrations: Based on the minimum inhibitory concentration MIC obtained in step S2, different drug concentrations were set: 0.5×MIC, 1×MIC, 2×MIC, 4×MIC, 8×MIC, 16×MIC, 32×MIC, 64×MIC, and drug solutions of different concentrations were added to M7H10 broth pre-warmed at 37°C and vortexed; logarithmic phase Mycobacterium tuberculosis colonies were added to the broth, cultured in a 37°C, 5% CO2 incubator, and samples were taken on days 0, 1, 3, 7, 10, and 14, respectively, and stored at low temperature for later use; S4 negative control group: take the bacterial solution in step S3, add buffer solution, mix well, and use it as negative control group; S5 compensation adjustment group: take two groups of bacterial liquid incubated with drugs in step S3, add DMAO staining working solution to one group, and add PI staining working solution to the other group as compensation adjustment groups; S6 Experimental group double fluorescence staining: Take the bacterial solution in step S3, add DMAO and PI staining working solution, mix well, and use this as the experimental group; S7 flow cytometer detection: Incubate the samples in each group of steps S4, S5, and S6 at 37°C in the dark for 15 minutes, and then place them in a flow cytometer to count the bacterial solution to obtain the count data of live bacteria in the bacterial solution to be tested; S8 Fitting the bactericidal curve to determine the optimal inhibitory concentration: According to the count data of live bacteria in the test bacterial solution, the bactericidal curve of drug concentration-Mycobacterium tuberculosis is fitted to obtain the drug concentration corresponding to the optimal bactericidal effect of the drug on Mycobacterium tuberculosis.
[0007] The specific process of step S1 is as follows: S11 Add 1-2 drops of 10% Tween-80 solution to the thawed strain in a grinding bottle with glass beads; S12 Use a sterile inoculation loop to scrape fresh colonies from 2 to 3 weeks old and place them in a grinding bottle; S13 Tighten the bottle cap and oscillate on a vortex oscillator for 10 to 20 seconds; S14 was allowed to stand for 30 minutes, then the bottle cap was carefully opened, and about 2 ml of sterile saline was added, and it was allowed to stand for a while to allow the bulk substances in the bacterial solution to settle; S15 Use a sterile pipette to absorb about 1 ml of the bacterial solution in the middle and upper part, transfer it to another sterile test tube, and compare the turbidity with McFarland No. 1 standard turbidimetric tube; S16 Gradually add sterile saline until the turbidity of the bacterial solution is consistent with that of McFarland No. 1 standard turbidity tube, that is, a 1 mg / ml bacterial solution is obtained.
[0008] The specific process of step S7 is as follows: S71 parameter setting: collect negative control group samples on the flow cytometer, set forward scatter and side scatter parameters, move the negative control group to the appropriate area, and circle the target cells. Adjust the voltage in the PI and DMAO channels so that the fluorescence histogram of the negative control group is within the first order of the fluorescence logarithmic scale; S72: using the samples in the adjustment compensation group, adjusting the fluorescence compensation: making the fluorescence histogram of the DMAO-positive sample within the second order of the fluorescence logarithmic scale, and the fluorescence histogram of the PI-positive sample within the fourth order of the fluorescence logarithmic scale; setting a gate on the negative peak within the first order, setting a gate on the positive peak within the second order, and setting a gate on the positive peak within the fourth order; and then calculating the compensation and applying it to the sample tube; For the S73 experimental group sample analysis, the fluorescence detection results were viewed using a two-dimensional scatter plot of FL1 (533 / 30 BP) and FL3 (610 / 20 BP) logarithmic scale; a two-parameter scatter plot was created; a polygon gate P2 was used to circle the PI-positive cell population, and P4 was used to circle the PI-positive + DMAO-positive cell population, and a statistical table was drawn to calculate the total number of cells and the P2-positive percentage. The average of the three experiments was taken and recorded.
[0009] Furthermore, the excitation wavelength of the flow cytometer is 488 nm.
[0010] Furthermore, the concentration of DMAO and PI staining working solution was 100X.
[0011] Beneficial technical effects achieved by the present invention: The present invention provides a method for testing the bactericidal effect of antibacterial drugs on Mycobacterium tuberculosis therapeutic drugs by flow cytometry, which combines flow cytometry and counting methods to complete the detection of the survival status of Mycobacterium tuberculosis in samples within 3 hours, which is much faster than the 28 days of the traditional method. This method is not only of great significance in non-clinical pharmacokinetics, but also provides a solid theoretical basis for clinical testing of the bactericidal effect of antibacterial drugs on Mycobacterium tuberculosis. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 The bactericidal curve of isoniazid against Mycobacterium tuberculosis in one embodiment of the present invention; Figure 2 The flow cytometry analysis results of an embodiment of the present invention; Figure A is the flow cytometry test result of the bactericidal test of Mycobacterium tuberculosis with 1×MIC concentration of isoniazid on the 14th day; Figure B is the flow cytometry test result of the bactericidal test of Mycobacterium tuberculosis with 16×MIC concentration of isoniazid on the 14th day. DETAILED DESCRIPTION
[0013] The present invention will be further described below in conjunction with specific examples. The following examples are only used to more clearly illustrate the technical solutions of the present invention, and are not intended to limit the scope of protection of the present invention.
[0014] The present invention is further described below in conjunction with the accompanying drawings and embodiments.
[0015] The reagents used in the examples of this application are as follows: Bacterial turbidimetric tube: dispense physiological saline (or phosphate buffer, etc.) into test tubes, each containing 9 mL, sterilize (sterilize at 121°C for 15-30 min), and set aside.
[0016] Preparation of isoniazid stock solution: Use isoniazid powder (Sigma) to prepare, take 100 mL of normal saline, dissolve 100 mg of isoniazid powder, then the concentration of isoniazid is 1 mg / mL; M7H10 agar control agar medium: weigh 19.47 g of M7H10 agar powder (M7H10 Agar Base, Sigma), resuspend in 900 ml of distilled water, add 5 mL of glycerol, heat to completely dissolve the medium, sterilize at 121°C for 10 min, cool to 45°C or lower, add 20 mL of OADC growth supplement (Sigma), mix well and set aside; M7H10 agar drug-containing agar medium: Weigh 19.47 g of M7H10 agar dry powder, resuspend with 900 ml of distilled water, add 5 mL of glycerol, heat to completely dissolve the medium, sterilize at 121°C for 10 min, cool to 45°C or lower, add 20 mL of AD C growth additive (Sigma), and mix well; use a pipette to mix 20 uL, 50 uL, and 100 uL of isoniazid stock solution with 100 mL of fresh agar medium to obtain 0.2 ug / mL, 0.5 ug / mL, and 1 ug / mL of drug-containing medium, respectively; pour the drug-containing medium into disposable sterile culture dishes (9 cm), with each dish using approximately 20 mL, and set aside.
[0017] DMAO / PI staining kit (Beyotime, catalog number C2030S); BD FACSFlow™ Flow Cytometry Sheath Fluid (Cat. No. 342003) Example 1 Detection cycle experiment Using Mycobacterium tuberculosis H37Ra and isoniazid as an example, the in vitro bactericidal effect of isoniazid on Mycobacterium tuberculosis was determined. The specific process is as follows: S1 Preparation of bacterial solution to be tested: Thawing of strains: Thaw the Mycobacterium tuberculosis strains frozen in -80℃ liquid nitrogen and M7H10 medium, inoculate in fresh M7H10 medium, and culture at 37℃, 5% CO2. The experiment needs to ensure that the bacteria are in the logarithmic growth phase, generally within 1-2 weeks after the initial growth, when visible colonies appear. This step takes about 2-3 weeks.
[0018] Preparation of bacterial suspension: Add 1 to 2 drops of 10% Tween-80 solution to the grinding bottle with glass beads.
[0019] Use a sterile inoculation loop to scrape fresh colonies from 2 to 3 weeks old and place them in a grinding bottle. Pay attention to scraping colonies from all parts of the slope as much as possible, and avoid picking 1 or 2 individual colonies for testing. The amount of colonies scraped should be half a ring or a ring (5 to 10 mg).
[0020] Tighten the cap and vortex on a vortex shaker for 10 to 20 seconds.
[0021] Let it stand for 30 minutes, carefully open the bottle cap, add about 2 ml of sterile saline, and let it stand for a while to allow the large pieces of matter in the bacterial solution to settle.
[0022] Use a sterile pipette to absorb about 1 ml of the bacterial solution in the middle and upper part, transfer it to another sterile test tube, and compare the turbidity with McFarland No. 1 standard turbidimetric tube.
[0023] Gradually add sterile saline until the turbidity of the bacterial solution is consistent with that of the McFarland No. 1 standard turbidimetric tube, thus obtaining a 1 mg / ml bacterial solution.
[0024] Bacterial dilution: Use a sterile pipette to add 2 ml of sterile saline to a sterile test tube with a screw cap and set aside. Prepare 2 tubes for each strain of bacteria to be tested.
[0025] The bacterial solution is allowed to stand until the particles or bacterial lumps settle.
[0026] Use a 22 SWG standard inoculation loop to take 2 full loops of approximately 1 mg / ml bacterial solution and add it to 2 ml of sterile saline to dilute it to 10 -2 times.
[0027] Use a 22 SWG standard inoculation loop to take 2 full loops of 10 -2 The diluted bacterial solution was added to another 2 ml of sterile saline solution, and then diluted 100 times, i.e. the final dilution was 10 -4 times the bacterial liquid.
[0028] S2 Detection of the sensitivity of Mycobacterium tuberculosis to isoniazid: Use a 22 SWG standard inoculation loop to take a full loop (i.e. 0.01 ml) of 10 -2 mg / ml and 10 -4 mg / ml bacterial solution was evenly inoculated onto the surface of neutral modified Roche medium and isoniazid-containing medium as a control by streaking method. Care should be taken to ensure that the bacterial solution is as evenly dispersed as possible on the slant of the medium. The isoniazid concentrations were 0.2 ug / mL, 0.5 ug / mL, and 1 ug / mL, respectively.
[0029] The final inoculum volume was 10 -4 mg / ml and 10 -6 mg / ml bacteria.
[0030] Incubation The inoculated culture medium was placed on a horizontal shelf and kept horizontal on the slant surface at 36±1°C for 24 hours, then cultured upright for 4 weeks.
[0031] The interpretation criteria are shown in Table 1.
[0032] Table 1 Colony growth Reporting method No colony growth — Less than 50 colonies Actual colony count 50-100 colonies 1+ 100-200 colonies 2+ Mostly confluent (200-500 colonies) 3+ Fusion (greater than 500 colonies) 4+ Compare the countable colonies on the drug-containing medium with the countable colonies on the control medium. If the value is greater than 1%, it is considered to be drug-resistant. -4 If the number of colonies growing on the control medium is less than 20 (mg / mL), the control tube should be subcultured and the test should be repeated. The results are shown in Table 2.
[0033] Table 2
[0034] The results in Table 2 show that the MIC of Mycobacterium tuberculosis H37Ra to isoniazid is 0.5 ug / mL.
[0035] S3 Bactericidal test of different concentrations of isoniazid on Mycobacterium tuberculosis: Based on the MIC of Mycobacterium tuberculosis to isoniazid obtained above, 8 concentration gradients were set in a 2-fold increment method using M7H10 broth pre-warmed at 37°C as diluent, namely: 0.5×MIC, 1×MIC, 2×MIC, 4×MIC, 8×MIC, 16×MIC, 32×MIC, 64×MIC, i.e. 0.25ug / mL, 0.5ug / mL, 1ug / mL, 2ug / mL, 4ug / mL, 8ug / mL, 16ug / mL, 32ug / mL. A blank control group (Control) without drug was also set.
[0036] Take the colonies of Mycobacterium tuberculosis H37Ra cultured to the logarithmic phase and use a turbidimetric tube to make a 0.5 McFarland turbidimetric concentration (1.5×10 7 CFU / mL), and then transfer 1 mL to the M7H10 broth containing different concentrations of antibiotics to make the final bacterial concentration 1.5×10 5 CFU / mL, which is taken as time 0, and the cells are immediately placed in an incubator at 37°C and 5% CO2. Samples are taken at 0, 1, 3, 7, 10, 14, and 28 days and stored at low temperature for later use.
[0037] Result analysis: The bacterial suspension treated with different isoniazid concentrations was analyzed by flow cytometry, and the traditional colony counting method was used as a control.
[0038] Among them, the analysis process of flow cytometry is as follows: S4 negative control group: take the bacterial solution in step S3, add buffer solution, mix well, and use it as negative control group; S5 Compensation adjustment group preparation: Take two groups of bacterial liquid incubated with antibiotics in step S2, add DMAO staining working solution to one group, and add PI staining working solution to the other group; S6 Experimental group double fluorescence staining: Take the bacterial solution in step S3, add DMAO and PI staining working solution, mix well, and use this as the experimental group; Flow cytometer detection: Incubate the bacterial solutions of steps S4, S5, and S6 at 37°C in the dark for 15 minutes, then place them in a flow cytometer to count the bacterial solutions to be tested and obtain the count data of live bacteria in the bacterial solutions to be tested. The specific process is as follows: Bacteria were detected using a BD Accuri C6 Plus (4-color) analyzer with an excitation wavelength of 488 nm. DMAO was detected as green fluorescence, Ex / Em = 503 / 530 nm, in the CV channel (533 / 30 BP); PI was detected as red fluorescence, Ex / Em = 535 / 617 nm, in the PI channel (610 / 20 BP).
[0039] Parameter setting: Collect negative control group samples on the flow cytometer, set forward scatter and side scatter parameters, move the negative control group to the appropriate area, and circle the target cells. Adjust the voltage in the PI and DMAO channels so that the fluorescence histogram of the negative control group is within the first order of the fluorescence logarithmic scale; Using the samples in the compensation adjustment group, perform fluorescence compensation adjustment: make the fluorescence histogram of DMAO-positive samples within the second order of the fluorescence logarithmic scale, and the fluorescence histogram of PI-positive samples within the fourth order of the fluorescence logarithmic scale; set a gate on the negative peak within the first order, set a gate on the positive peak within the second order, and set a gate on the positive peak within the fourth order. Then calculate the compensation and apply it to the sample tube.
[0040] For the analysis of the experimental group samples, the fluorescence detection results were viewed using a two-dimensional scatter plot of FL1 (533 / 30 BP) and FL3 (610 / 20 BP) with logarithmic scales; a two-parameter scatter plot was created; a polygon gate P2 was used to circle the PI-positive cell population, and P4 was used to circle the PI-positive + DMAO-positive cell population, and a statistical table was drawn to calculate the total number of cells and the P2-positive percentage. The average of the three experiments was taken and recorded, and the results are shown in Tables 3 and Figure 2 shown.
[0041] Table 3
[0042] Figure 2 Figure 1 is an example of flow cytometry. Figure A is the flow cytometric test result of the bactericidal test of isoniazid at 1×MIC concentration on Mycobacterium tuberculosis on the 14th day; Figure B is the flow cytometric test result of the bactericidal test of isoniazid at 16×MIC concentration on Mycobacterium tuberculosis on the 14th day.
[0043] Table 3 shows the counting results of the flow cytometer. It can be seen from the table that since the effective counting range of the flow cytometer is wide and no prior dilution is required, the counting results obtained are all effective and the test efficiency is high.
[0044] The specific process of traditional colony counting method is as follows: The samples in the S3 bactericidal test were simultaneously subjected to the traditional method as a comparative experiment: 5 concentrations were tested, negative control, 1×MIC, 2×MIC, 4×MIC, 8×MIC, i.e. control, 0.5ug / mL, 1ug / mL, 2ug / mL, 4ug / mL, 8ug / mL; that is, the bacterial solution was taken on days 0, 1, 3, 7, 10, 14, and 28, and each sample was diluted 100 times and 10 times with physiological saline, and 10uL was inoculated on the neutral modified Roche medium, placed in an incubator for culture, cultured for 28 days, and the colonies were counted. Since the effective range of colony counts is generally 20-300 colonies, only the effective results in the range of two culture samples with different dilution gradients of each sample were recorded. The results are shown in Table 4.
[0045] Table 4
[0046] NA: Outside the valid range for colony count.
[0047] According to the flow cytometry analysis method and the traditional analysis method, it can be seen that: through the significance analysis (α=0.05), the average values of the two methods are not significantly different, and the CV (coefficient of variation) values are significantly different. This shows that the detection results of flow cytometry and traditional methods are close, with good accuracy and higher precision than traditional methods.
[0048] At the same time, it can be seen during the test that the traditional method relies on colony counting. It is generally believed that the effective counting range of colony counting is 20-300 colonies. Too many or too few colonies will be judged invalid because they affect the accuracy of the test. Therefore, when using traditional methods, most of them need to conduct preliminary experiments to estimate the parameters used in the formal test (especially the dilution multiple of the bacterial solution), and it is impossible to ensure that the difference between the formal test and the preliminary experiment is controllable. As can be seen from Table 4, when the amount of bacteria is large in the test, the counting results are judged invalid because they exceed the effective counting range of colony counting (invalid results account for 37.1%), and the test efficiency is low. The effective counting range of the flow cytometer is wide, and no prior solution dilution is required. It can be seen that the efficiency and convenience of the flow cytometer are greatly improved compared with the traditional method.
[0049] Furthermore, the flow cytometry analysis process only takes 2-3 hours, while the traditional analysis method requires 28 days of culture before counting and analysis. Therefore, the use of flow cytometry analysis can greatly save analysis time.
[0050] S7 fitted the sterilization curve to determine the drug concentration corresponding to the best sterilization effect: According to the count data of live bacteria in the test solution, the antibiotic concentration-Mycobacterium tuberculosis bactericidal curve is fitted to obtain the drug concentration corresponding to the best bactericidal effect of antibiotics on Mycobacterium tuberculosis. The results are as follows: Figure 1 shown.
[0051] Conclusion: The bactericidal effect of different concentrations of isoniazid on Mycobacterium tuberculosis was analyzed by flow cytometry, and the entire analysis process took only 2-3 hours, while the traditional method would take 4 weeks.
[0052] The present invention has been disclosed above with preferred embodiments, but they are not intended to limit the present invention. Any technical solutions obtained by adopting equivalent replacement or equivalent transformation solutions fall within the protection scope of the present invention.
Claims
1. A method for determining the in vitro bactericidal effect of an antibacterial drug on Mycobacterium tuberculosis using flow cytometry, characterized in that: The bactericidal effect of Mycobacterium tuberculosis after being acted on by gradient concentrations of antibacterial drugs was analyzed by flow cytometry to obtain the drug concentration with the best bactericidal effect on Mycobacterium tuberculosis in vitro.
2. The method according to claim 1, characterized in that The following steps are involved: S1 Preparation of bacterial solution to be tested; S2 Drug sensitivity test of Mycobacterium tuberculosis: Using the proportional method, the minimum inhibitory concentration (MIC) of Mycobacterium tuberculosis is determined by counting colonies; S3 Bactericidal test of drugs at different concentrations: Based on the minimum inhibitory concentration MIC obtained in step S2, different drug concentrations were set: 0.5×MIC, 1×MIC, 2×MIC, 4×MIC, 8×MIC, 16×MIC, 32×MIC, 64×MIC, and drug solutions of different concentrations were added to M7H10 broth pre-warmed at 37°C and vortexed; logarithmic phase Mycobacterium tuberculosis colonies were added to the broth, cultured in a 37°C, 5% CO2 incubator, and samples were taken on days 0, 1, 3, 7, 10, and 14, respectively, and stored at low temperature for later use; S4 negative control group: take the bacterial solution in step S3, add buffer solution, mix well, and use it as negative control group; S5 compensation adjustment group: take two groups of bacterial liquid incubated with drugs in step S3, add DMAO staining working solution to one group, and add PI staining working solution to the other group as compensation adjustment groups; S6 Experimental group double fluorescence staining: Take the bacterial solution in step S3, add DMAO and PI staining working solution, mix well, and use this as the experimental group; S7 flow cytometer detection: Incubate the samples in each group of steps S4, S5, and S6 at 37°C in the dark for 15 minutes, and then place them in a flow cytometer to count the bacterial solution to obtain the count data of live bacteria in the bacterial solution to be tested; S8 Fitting the bactericidal curve to determine the optimal inhibitory concentration: According to the count data of live bacteria in the test bacterial solution, the bactericidal curve of drug concentration-Mycobacterium tuberculosis is fitted to obtain the drug concentration corresponding to the optimal bactericidal effect of the drug on Mycobacterium tuberculosis.
3. The method according to claim 2, characterized in that: The specific process of step S1 is as follows: S11 Add 1-2 drops of 10% Tween-80 solution to the thawed strain in a grinding bottle with glass beads; S12 Use a sterile inoculation loop to scrape fresh colonies from 2 to 3 weeks old and place them in a grinding bottle; S13 Tighten the bottle cap and oscillate on a vortex oscillator for 10 to 20 seconds; S14 was allowed to stand for 30 minutes, then the bottle cap was carefully opened, and about 2 ml of sterile saline was added, and it was allowed to stand for a while to allow the bulk substances in the bacterial solution to settle; S15 Use a sterile pipette to absorb about 1 ml of the bacterial solution in the middle and upper part, transfer it to another sterile test tube, and compare the turbidity with McFarland No. 1 standard turbidimetric tube; S16 gradually add sterile saline until the turbidity of the bacterial solution is consistent with that of the McFarland No. 1 standard turbidity tube, that is, a 1 mg / ml bacterial solution is obtained.
4. The method according to claim 2, characterized in that: The specific process of step S7 is as follows: S71 parameter setting: collect negative control group samples on the flow cytometer, set forward scatter and side scatter parameters, move the negative control group to the appropriate area, and circle the target cells. Adjust the voltage in the PI and DMAO channels so that the fluorescence histogram of the negative control group is within the first order of the fluorescence logarithmic scale; S72: using the samples in the adjustment compensation group, adjusting the fluorescence compensation: making the fluorescence histogram of the DMAO-positive sample within the second order of the fluorescence logarithmic scale, and the fluorescence histogram of the PI-positive sample within the fourth order of the fluorescence logarithmic scale; setting a gate on the negative peak within the first order, setting a gate on the positive peak within the second order, and setting a gate on the positive peak within the fourth order; and then calculating the compensation and applying it to the sample tube; For the S73 experimental group sample analysis, the fluorescence detection results were viewed using a two-dimensional scatter plot of FL1 (533 / 30 BP) and FL3 (610 / 20 BP) logarithmic scale; a two-parameter scatter plot was created; a polygon gate P2 was used to circle the PI-positive cell population, and P4 was used to circle the PI-positive + DMAO-positive cell population, and a statistical table was drawn to calculate the total number of cells and the P2-positive percentage. The average of the three experiments was taken and recorded.
5. The method for determining the optimal dosage of Mycobacterium tuberculosis by flow cytometry according to claim 4, characterized in that: The excitation wavelength of the flow cytometer was 488 nm.
6. The method for determining the optimal dosage of Mycobacterium tuberculosis by flow cytometry according to claim 2, characterized in that: The concentration of DMAO and PI staining working solution is 100X.
